seminar dates: August 27- 30, 2024
locations:
Hyderabad - 27 August: Avasa Hotel, Plot No 15, 24 25 & 26, Survey No. 64, Sector 1, Huda Techno Enclave, Madhapur, Hyderabad, 500081
Ahmedabad - 28 August: Novotel Hotel, Iscon Cross Roads, Next To Wide Angle Cinema, S G Highway, Ahmedabad, 380015
Mumbai - 30 August: Holiday Inn, Mumbai International Airport, Sakinaka Junction, Mumbai, 400072
Learn more about Ashland innovative technology platforms, rooted in ESG principles that address formulator needs, regulatory actions, and global consumer desires for differentiated, high-performance products. Ashland’s deep expertise in naturally derived cellulose and polymer technology can help you create products with astounding potential for increasing the sustainability of your products.
Ashland offers the broadest selection of ingredients to compose effective pharmaceutical excipients. We are widening our portfolio of cellulose-based polymers (HPMC, HPC, CMC, HEC), growing our excipient portfolio for injectables/biologics, including the possibility for customization, and focusing on film coatings. Oral solid dosage and liquid dosage ingredients, controlled release functionality, coatings, disintegrants, binders, and now, injectables compose Ashland’s pharma portfolio.
Join the seminar to learn about:
- polymer engineering for robust extended release formulations
- excipients for sustainable pharmaceutical manufacturing
- new introductions to meet your sustainability goals
At the seminar we will introduce:
And we are featuring recent additions to our portfolio:
- polyplasdone™ plus multifunctional disintegrant is a direct compression superdisintegrant containing silica and lubricant. This highly effective new product provides enhanced flow properties, self-lubrication, and enhanced tablet performance, improving overall manufacturing through-put time.
- klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency. It is the latest addition to our klucel™ product line and further expands our controlled-release portfolio. Ashland’s step change klucel™ xtend HPC, has been shown to match the release profile of hypromellose controlled-release formulations at half the polymer concentration.
- aquarius™ film-coating systems are our line of fully formulated, easily dispersed and ready-to-use have a range of functions to meet your needs: aesthetic or functional coatings, white or colored, with or without TiO2.
We offer the broadest selection of ingredients to compose effective pharmaceutical excipients. Migrating towards high impact and high value, we are widening our portfolio of cellulose-based polymers (HPMC, HPC, CMC, HEC), growing our excipient portfolio for injectables/biologics, including the possibility for customization, and focusing on film coatings. Oral solid dosage and liquid dosage ingredients, controlled release functionality, coatings, disintegrants, binders, and now, injectables compose Ashland’s pharma portfolio, and it is the diamond at the center of Ashland.
